RLMD is currently covered by 1 analysts with an average price target of $19. This is a potential upside of $16.38 (625.19%) from yesterday's end of day stock price of $2.62.
Relmada Therapeutics's activity chart (see below) currently has 42 price targets and 48 ratings on display. The stock rating distribution of RLMD is 100% BUY.
Analysts' price targets on this stock were met 17.36% of the time, taking 89.23 days on average.
Highest price target for RLMD is $19, Lowest price target is $19, average price target is $19.
Most recent stock forecast was given by UY EAR from MIZUHO on 08-Apr-2026. First documented stock forecast 15-Dec-2019.
Currently out of the existing stock ratings of RLMD, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Mar-2026
$19
$16.38 (625.19%)
7 months 13 days ago
(08-Apr-2026)
2/11 (18.18%)
$11.99 (171.04%)
236
Buy Since 10-Jan-2020
$1
$10
1 years 11 months 17 days ago
(04-Dec-2024)
2/6 (33.33%)
$0.37 (58.73%)
158
Buy Since 16-Nov-2021
$25
2 years 13 days ago
(07-Nov-2024)
0/5 (0%)
$21.73 (664.53%)
Hold Since 17-Sep-2024
$13
$75
2 years 2 months 4 days ago
(17-Sep-2024)
0/3 (0%)
$9.56 (277.91%)
Hold Since 05-Jun-2024
$2
2 years 5 months 16 days ago
(05-Jun-2024)
1/2 (50%)
$-0.96 (-32.43%)
182
What is RLMD (Relmada Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on RLMD (Relmada Therapeutics)?
Which analyst has the most public recommendations on RLMD (Relmada Therapeutics)?
Which analyst is the currently most bullish on RLMD (Relmada Therapeutics)?
Which analyst is the currently most reserved on RLMD (Relmada Therapeutics)?